| Literature DB >> 35622574 |
Sara Taha Abdelkhalek1,2, Sherein Saied Abdelgayed3, Hong Jiang4, Man-Qun Wang1.
Abstract
Eichhornia crassipes were evaluated in order to investigate the insecticidal activity towards Aphis craccivora adults. The LC50 values were promising and reflected the bio-efficacy of the tested extracts (39 and 42 mg/L), respectively, and reduced the fecundity markedly. Using GC/MS analysis, the major components were n-hexadecanoic, linolenic, hexadecenoic, myristic, stearic acids, linolelaidic acid, methyl ester and some terpenoids, alkaloids, and hydrocarbons. A safety assessment of non-target organisms is essential for the development of new pesticides. In order to guide the rational use of the most potential insecticidal extracts AcF and EtF, the effect of these extracts on body weight, hematological indices, biochemical indicators, and histopathology of some relevant organs of albino rats (as a model for mammals) was investigated. The research outcomes revealed that the LC50 of AcF and EtF extracts had gradually raised body weight for 14 days (p > 0.05). Similarly, there were no remarkable alternations in the complete blood count (CBC); only a slight decrease in the monocytes count (612 ± 159.80 × 103 µL) in the EtF-treated group. There was a notable increase in alanine transferase (ALT) activity (36.73 ± 1.44 IU/L) in the AcF-treated group. No destructive changes were noted with the remaining biochemical parameters. Cholesterol and triglycerides non-significantly increased in the EtF group, whereas, cholesterol levels decreased significantly in the AcF group. In addition, histopathological examination reflected minor changes in AcF and EtF groups in the form of mild inflammation in the lungs and mild vacuolar degeneration in the kidneys, while no lesions were detected in the heart and liver in the same groups. Thus, the present research suggested that AcF and EtF extracts of E. crassipes are safe green insecticides for insect control strategies.Entities:
Keywords: GC/MS analysis; acetone extract of E. crassipes; bean aphid; bioassay; biochemical assessment; ethanol extract of E. crassipes; hematological indices; histopathology
Mesh:
Substances:
Year: 2022 PMID: 35622574 PMCID: PMC9144080 DOI: 10.3390/toxins14050327
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 5.075
Chemical composition of acetone and ethanol fraction extracts of Eichhronia crassipes.
| RT (min.) | Compound Name | RP Area (%) | MWt. | MF |
|---|---|---|---|---|
| Acetone Fraction Extract | ||||
| 27.01 | 12,15-Octadecadiynoic acid, methyl ester | 2.21 | 290 | C19H30O2 |
| 27.64 | 6-phenylundecane | 1.08 | 232 | C17H28 |
| 27.73 | 5-phenylundecane | 1.14 | 232 | C17H28 |
| 27.97 | 4-phenylundecane | 1.13 | 232 | C17H28 |
| 28.48 | 3-phenylundecane | 1.55 | 232 | C17H28 |
| 29.37 | 2-phenylundecane | 2.83 | 232 | C17H28 |
| 29.85 | 6-Phenyldodecane | 2.08 | 246 | C18H30 |
| 29.95 | 5-Phenyldodecane | 1.51 | 246 | C18H30 |
| 30.23 | 4-Phenyldodecane | 1.40 | 246 | C18H30 |
| 30.73 | 3-Phenyldodecane | 1.86 | 246 | C18H30 |
| 31.23 | Myristic acid | 1.24 | 228 | C14H28O2 |
| 31.60 | 2-Phenyldodecane | 2.75 | 246 | C18H30 |
| 31.96 | 6-phenyltridecane | 1.93 | 260 | C19H32 |
| 32.10 | 5-phenyltridecane | 1.18 | 260 | C19H32 |
| 32.15 | Neophytadiene | 2.39 | 278 | C20H38 |
| 32.39 | Hexahydrofarnesyl acetone | 9.03 | 268 | C18H36O |
| 32.66 | 3,7,11,15-Tetramethyl-2 hexadecen-1-ol | 1.00 | 296 | C20H40O |
| 32.90 | 3-phenyltridecane | 1.82 | 260 | C19H32 |
| 33.72 | 2-Phenyltridecane | 2.24 | 260 | C19H32 |
| 33.92 | Hexa-hydro-farnesol | 2.60 | 228 | C15H32O |
| 34.82 | Cyclopropanenonanoic acid,2-[(2-butylcyclopropyl) methyl]-, methyl ester | 1.18 | 322 | C21H38O2 |
| 35.41 | Hexadecanoic acid | 9.35 | 256 | C16H32O2 |
| 35.62 | 16.72 | 256 | C16H32O2 | |
| 37.28 | Linolelaidic acid, methyl ester | 1.34 | 294 | C19H34O2 |
| 37.40 | 8-Octadecenoic acid, methyl ester | 2.16 | 296 | C19H36O2 |
| 37.65 | Phytol | 3.79 | 296 | C20H40O |
| 38.69 | Linolenic acid | 11.13 | 278 | C18H30O2 |
| 38.95 | Octadecanoic acid | 1.89 | 284 | C18H36O2 |
| 44.71 | Phthalic acid, bis (2 ethylhexyl) ester | 2.04 | 390 | C24H38O4 |
| 48.45 | Phthalic acid, dinonyl ester | 1.12 | 418 | C26H42O4 |
| Ethanol Fraction Extract | ||||
| 26.99 | Lauric acid | 1.17 | 200 | C12H24O2 |
| 27.62 | Undecane, 6-phenyl- | 1.06 | 232 | C17H28 |
| 27.71 | Undecane, 5-phenyl- | 1.05 | 232 | C17H28 |
| 27.96 | Undecane, 4-phenyl- | 1.26 | 232 | C17H28 |
| 28.47 | Undecane, 3-phenyl | 1.59 | 232 | C17H28 |
| 29.36 | Undecane, 2-phenyl- | 3.37 | 232 | C17H28 |
| 29.85 | Dodecane, 6-phenyl- | 3.01 | 246 | C18H30 |
| 29.95 | Dodecane, 5-phenyl- | 2.54 | 246 | C18H30 |
| 30.23 | Dodecane, 4-phenyl- | 2.59 | 246 | C18H30 |
| 30.74 | Dodecane, 3-phenyl- | 3.49 | 246 | C18H30 |
| 31.25 | Tetradecanoic acid | 1.15 | 228 | C14H28O2 |
| 31.62 | 2-Phenyldodecane | 6.22 | 246 | C18H30 |
| 31.99 | 6-Phenyltridecane | 4.99 | 260 | C19H32 |
| 32.13 | 5-Phenyltridecane | 3.66 | 260 | C19H32 |
| 32.40 | 4-Phenyltridecane | 3.56 | 260 | C19H32 |
| 32.91 | 3-Phenyltridecane | 4.47 | 260 | C19H32 |
| 33.76 | Tridecane, 2-phenyl- | 6.30 | 260 | C19H32 |
| 34.05 | Hexadecanoic acid, methyl ester | 3.04 | 270 | C17H34O2 |
| 35.38 | Hexadecanoic acid, ethyl ester | 7.86 | 284 | C18H36O2 |
| 35.56 | Hexadecanoic acid | 5.51 | 256 | C16H32O2 |
| 37.40 | 9-Octadecenoic acid (Z)-, methyl ester | 2.76 | 296 | C19H36O2 |
| 38.46 | Ethyl linoleate | 1.27 | 308 | C20H36O2 |
| 38.57 | Oleic acid | 3.39 | 282 | C18H34O2 |
| 44.72 | Diisooctyl phthalate | 2.48 | 390 | C24H38O4 |
| 47.07 | 11-Hydroxyascididemin | 1.17 | 299 | C18H9N3O2 |
| 47.19 | Dodecyl cis-9,10-epoxyoctadecanoate | 1.09 | 466 | C30H58O3 |
| 47.46 | 1,2-Cyclohexanedicarboxylicacid, nonyl 4-octyl ester | 1.39 | 410 | C25H46O4 |
| 47.54 | 1,2-Cyclohexane dicarboxylic acid diisononyl ester | 1.19 | 424 | C26H48O4 |
| 47.78 | 1,2-Cyclohexanedicarboxylicacid, cyclohexylmethyl nonylester | 1.05 | 394 | C24H42O4 |
| 47.90 | 1,2-Cyclohexanedicarboxylicacid, nonyl 4-octyl ester | 1.41 | 410 | C25H46O4 |
RT: Retention time; RP area: Relative peak area; MWt: Molecular weight; MF: Molecular formula.
Figure 1Mortality percentages of AcF extract of E. crassipes against A. craccivora.
Figure 2Mortality percentages of EtF extract of E. crassipes against A. craccivora.
Efficacy of AcF and EtF extracts against Aphis craccivora.
| Treatment | LC50 (mg/L) | Upper Limit | Lower Limit | Slope ± SE |
|---|---|---|---|---|
| AcF (24 h) | 64 | 76 | 55 | 3.14 ± 0.28 |
| AcF (48 h) | 52 | 57 | 48 | 4.67 ± 0.50 |
| AcF (72 h) | 39 | 42 | 36 | 3.66 ± 0.21 |
| EtF (24 h) | 140 | 210 | 94 | 1.86 ± 0.21 |
| EtF (48 h) | 86 | 110 | 66 | 1.88 ± 0.10 |
| EtF (72 h) | 42 | 48 | 36 | 2.03 ± 0.09 |
LC50; upper limit; lower limit their confidence limits at 95%.
Figure 3Effect of (a) acetone and (b) ethanol fractions on the fecundity of A. craccivora adults.
Figure 4Effect of acetone and ethanol fractions of E. crassipes extracts in albino rat’s body weight (g) (values are means for n = 5 ± SE). The columns that have the same letter do not show a significant difference (p > 0.05) compared to the control.
Effect of LC50 concentration of acetone and ethanol fractions extracts of E. crassipes on differential WBC count in albino rats.
| Blood Parameters | Treatment Samples | ||
|---|---|---|---|
| Control | Acetone Fraction | Ethanol Fraction | |
| WBC (×103/µL) | 12.83 ± 2.02 a | 14 ± 2 a | 11.17 ± 1.9 a |
| Lymphocytes (×103/µL) | 7453 ± 1348.51 a | 9360 ± 1440 a | 6555 ± 1262.71 a |
| Monocytes (×103/µL) | 1006 ± 255.60 a | 1260 ± 180 a | 612 ± 159.80 b |
| Neutrophils (×103/µL) | 3989 ± 369.75 a | 3000 ± 301.10 a | 3577.7 ± 536.17 a |
| Eosinophils (×103/µL) | 385 ± 60.56 a | 380 ± 87.18 a | 422 ± 67.30 a |
| Segmented (×103/µL) | 3860.7 ± 349.62 a | 2860 ± 282.13 a | 3466 ± 517.03 a |
The values are means ± SE (n = 5). Means that have the same letter do not show a significant difference (p > 0.05) compared to the control.
Effect of LC50 concentration of acetone and ethanol fractions extracts of E. crassipes on differential RBC count in albino rats.
| Blood Parameters | Treatment Samples | ||
|---|---|---|---|
| Control | Acetone Fraction | Ethanol Fraction | |
| RBC (×106/µL) | 5.80 ± 0.47 a | 5.57 ± 0.35 a | 5.40 ± 0.35 a |
| Hemoglobin (g/Dl) | 13.87 ± 0.49 a | 14.13 ± 0.52 a | 13.43 ± 0.24 a |
| Hematocrit (%) | 41 ± 1 a | 41.90 ± 1.63 a | 40 ± 1 a |
| MCV (fL) | 71.60 ± 5.80 a | 75.60 ± 3.19 a | 74.80 ± 5.86 a |
| MCH (ρg) | 24.29 ± 2.42 a | 25.52 ± 1.34 a | 25.1 ± 1.76 a |
| MCHC (g/dL) | 33.83 ± 0.69 a | 33.73 ± 0.37 a | 33.60 ± 0.29 a |
| Platelets (×103/µL) | 246.67 ± 4.81 a | 298 ± 4.58 a | 296.67 ± 6.36 a |
The values are means ± SE (n= 5). Means that have the same letter do not show a significant difference (p > 0.05) compared to the control.
Effect of LC50 concentration of acetone and ethanol fractions extracts of E. crassipes on liver and kidney functions in albino rats.
|
| |||||
|---|---|---|---|---|---|
| Control | 2.25 ± 0.29 a | 329.33 ± 2.40 a | 25.04 ± 1.99 a | 30.9 ± 0.53 a | 27.37 ± 0.40 a |
| Acetone fraction | 3.18 ± 0.52 a | 342.67 ± 4.63 a | 36.73 ± 1.44 b | 33.4 ± 1.07 a | 29.05 ± 0.52 a |
| Ethanol fraction | 2.65 ± 0.56 a | 329 ± 2.08 a | 35.13 ± 4.19 a | 34.10 ± 1.31 a | 28.67 ± 1.91 a |
The values are means ± SE (n = 5). Means that have the same letter do not show a significant difference (p > 0.05) compared to the control.
Figure 5Effect of acetone and ethanol fractions of E. crassipes extracts on total cholesterol and triglycerides (values are means for n = 5 ± SE) in albino rats. The columns that have the same letter do not show a significant difference (p > 0.05) compared to the control.
Figure 6Photomicrographs of heart, lungs, liver, and kidneys from different experimental groups stained with hematoxylin and eosin. (a) Heart from control group (Gp I) (0). (b) Heart from AcF group (Gp II) (0). (c) Heart from EtF group (Gp III) (0). (d) Lung from control group (Gp I) (0). (e) Lung from AcF group (Gp II) (+). (f) Lung from EtF group (Gp III) (+). (g) Liver from control group (Gp I) (0). (h) Liver from AcF group (Gp II) (0). (i) Liver from EtF group (Gp III) (0). (j) Kidneys from the control group (Gp I) (0). (k) Kidneys from AcF group (+). (l) Kidneys from EtF group (Gp III) (+).
Grading of histopathological lesions in heart, lungs, liver, and kidneys in all experimental groups.
| Organs | Grades of the Lesions | ||||
|---|---|---|---|---|---|
| 0 (Negative) | + (Mild) | ++ (Moderate) | +++ (Sever) | ||
|
|
|
| |||
|
|
| ||||
|
|
| ||||
|
|
| ||||
|
|
|
| |||
|
|
| ||||
|
|
| ||||
|
|
| ||||
|
|
|
| |||
|
|
| ||||
|
|
| ||||
|
|
| ||||